These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18276852)

  • 41. Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.
    Heilig M; Thorsell A; Sommer WH; Hansson AC; Ramchandani VA; George DT; Hommer D; Barr CS
    Neurosci Biobehav Rev; 2010 Nov; 35(2):334-44. PubMed ID: 19941895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective.
    Heilig M
    J Intern Med; 2023 May; 293(5):559-573. PubMed ID: 37052145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tension-reducing effects of alcohol: further evidence and some methodological considerations.
    Steffen JJ; Nathan PE; Taylor HA
    J Abnorm Psychol; 1974 Oct; 83(5):542-7. PubMed ID: 4455718
    [No Abstract]   [Full Text] [Related]  

  • 44. Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse.
    Barak S; Liu F; Ben Hamida S; Yowell QV; Neasta J; Kharazia V; Janak PH; Ron D
    Nat Neurosci; 2013 Aug; 16(8):1111-7. PubMed ID: 23792945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial.
    Tsianakas A; Luger TA; Radin A
    Br J Dermatol; 2018 Feb; 178(2):406-414. PubMed ID: 28845523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct bidirectional μ-opioid control of midbrain dopamine neurons.
    Margolis EB; Hjelmstad GO; Fujita W; Fields HL
    J Neurosci; 2014 Oct; 34(44):14707-16. PubMed ID: 25355223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of substance P and the NK-1 receptor in cancer progression.
    Muñoz M; Coveñas R
    Peptides; 2013 Oct; 48():1-9. PubMed ID: 23933301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder.
    Tauscher J; Kielbasa W; Iyengar S; Vandenhende F; Peng X; Mozley D; Gehlert DR; Marek G
    Eur Neuropsychopharmacol; 2010 Feb; 20(2):80-7. PubMed ID: 20018493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A new pharmacological treatment option for alcohol dependence discovered in transnational study: neurokinin-1 receptor antagonist as a possible therapy for alcoholism?].
    Mutschler J; Grosshans M; Kiefer F
    Neuropsychiatr; 2008; 22(4):283-5. PubMed ID: 19081000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuromedin U Neurons in the Edinger-Westphal Nucleus Respond to Alcohol Without Interfering with the Urocortin 1 Response.
    Medrano M; Allaoui W; Haddad RES; Makrini-Maleville L; Valjent E; Smolders I; Kormos V; Gaszner B; De Bundel D
    Neurochem Res; 2024 Sep; ():. PubMed ID: 39266897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mild and efficient synthesis and base-promoted rearrangement of novel isoxazolo[4,5-
    Nikol'skiy VV; Minyaev ME; Bastrakov MA; Starosotnikov AM
    Beilstein J Org Chem; 2024; 20():1069-1075. PubMed ID: 38774274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A meta-analysis of the neural substrates of monetary reward anticipation and outcome in alcohol use disorder.
    Zeng J; You L; Yang F; Luo Y; Yu S; Yan J; Liu M; Yang X
    Hum Brain Mapp; 2023 May; 44(7):2841-2861. PubMed ID: 36852619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circuit and neuropeptide mechanisms of the paraventricular thalamus across stages of alcohol and drug use.
    Hartmann MC; Pleil KE
    Neuropharmacology; 2021 Oct; 198():108748. PubMed ID: 34389397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional evaluation of NK
    Fonville L; Paterson L; Herlinger K; Hayes A; Hill R; Nutt D; Lingford-Hughes A
    Drug Alcohol Depend; 2021 Apr; 221():108564. PubMed ID: 33548897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The ventral pallidum and relapse in alcohol seeking.
    Prasad AA; McNally GP
    Br J Pharmacol; 2020 Sep; 177(17):3855-3864. PubMed ID: 32557550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alcohol dependence potentiates substance P/neurokinin-1 receptor signaling in the rat central nucleus of amygdala.
    Khom S; Steinkellner T; Hnasko TS; Roberto M
    Sci Adv; 2020 Mar; 6(12):eaaz1050. PubMed ID: 32206720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurokinin receptors in drug and alcohol addiction.
    Schank JR
    Brain Res; 2020 May; 1734():146729. PubMed ID: 32067964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of Centrally Projecting Edinger-Westphal Nucleus Neuropeptides in Actions of Addictive Drugs.
    Zuniga A; Ryabinin AE
    Brain Sci; 2020 Jan; 10(2):. PubMed ID: 31991932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurochemical Evidence of Preclinical and Clinical Reports on Target-Based Therapy in Alcohol Used Disorder.
    Prajapati SK; Bhaseen S; Krishnamurthy S; Sahu AN
    Neurochem Res; 2020 Feb; 45(2):491-507. PubMed ID: 31898084
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.